Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 12Pain, Postoperative 11Pain 11Breast Neoplasms 9Agnosia 9Depression 8Head and Neck Neoplasms 6Chronic Pain 4Anxiety Disorders 4Pancreatic Neoplasms 3Pain, Intractable 3Colorectal Neoplasms 3Acute Pain 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Mucositis 2Gastrointestinal Neoplasms 2Cancer Pain 2Stomatitis 1Spinal Stenosis 1Rectal Neoplasms 1Postoperative Analgesia 1Peripheral Nervous System Diseases 1Pelvic Neoplasms 1Pain, Procedural 1Otolaryngeal Cancer 1Neurotoxicity Syndromes 1Lymphoma, Follicular 1Lung Neoplasms 1Laparoscopic Colorectal Resection Due to Cancer 1

Interventions

Saline Solution 1Ketamine 1Electroencephalography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Otolaryngeal Cancer × Ketamine × Clear all
NCT03040024 2021-07-08

Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients

Emory University

Phase 4 Terminated
71 enrolled 17 charts
Head & Neck

Otolaryngeal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡